Clear Street Group Inc.

Position in DRMA — Dermata Therapeutics, Inc.

CIK 1881567 NEW YORK, NY

Position in DRMA

as of Dec 31, 2025 · filed Feb 13, 2026 Compact

Position Value

$39,440

New position

Shares Held

17,000

first reported quarter

Ownership

0.423%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Clear Street Group Inc. holds $24,636,408 across 4 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	APLS	Apellis Pharmaceuticals, Inc.	350,000	$14,080,500
2	SRPT	Sarepta Therapeutics, Inc.	361,391	$7,863,868
3	CNTN	Canton Strategic Holdings, Inc.	652,243	$2,132,834
4	MRNA	Moderna, Inc.	11,008	$559,206

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2025-12-31	$39,440	17,000	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.